Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LESS-DM: Pitavastatin vs Atorvastatin in Metabolic Syndrome
NCT02940366Phase 4Unknown
- Sponsor
- Seoul National University Hospital
- Start
- Dec 2016
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of pitavastatin in hypercholesterolemia (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Hemoglobin A1c at 24 months. Status: unknown.
02
Drugs
pitavastatin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT02940366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02940366.